Francis I. Perier's most recent trade in SpringWorks Therapeutics Inc was a trade of 368,923 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics Inc | Perier Francis I. | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 368,923 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Perier Francis I. | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | I. Francis Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 60,889 | 0 (0%) | 0% | - | Common Stock | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 34,419 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | I. Perier Francis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 14,724 | 0 | - | - | Performance Share Units | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 10 Jan 2025 | 34,419 | 34,419 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 10 Jan 2025 | 11,779 | 60,889 (0%) | 0% | 0 | Common Stock | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 04 Jan 2025 | 3,582 | 55,671 (0%) | 0% | 38.2 | 136,797 | Common Stock | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 04 Jan 2025 | 3,283 | 49,110 (0%) | 0% | 38.9 | 127,577 | Common Stock | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 04 Jan 2025 | 3,278 | 52,393 (0%) | 0% | 38.2 | 125,187 | Common Stock | |
| SpringWorks Therapeutics Inc | I. Francis Perier | Chief Financial Officer | 04 Jan 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | I. Francis Perier | Chief Financial Officer | 04 Jan 2024 | 21,156 | 64,619 (0%) | 0% | 0 | Common Stock | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 04 Jan 2024 | 3,215 | 59,253 (0%) | 0% | 41.5 | 133,519 | Common Stock | |
| SpringWorks Therapeutics Inc | Francis Perier I. | Chief Financial Officer | 04 Jan 2024 | 2,151 | 62,468 (0%) | 0% | 38.0 | 81,652 | Common Stock | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 07 Jan 2023 | 1,090 | 43,463 (0%) | 0% | 26.4 | 28,787 | Common Stock | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 05 Jan 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 05 Jan 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 05 Jan 2023 | 19,425 | 46,927 (0%) | 0% | - | Common Stock | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 05 Jan 2023 | 2,374 | 44,553 (0%) | 0% | 27.5 | 65,332 | Common Stock | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 07 Jan 2022 | 1,307 | 27,502 (0%) | 0% | 56.1 | 73,270 | Common Stock | |
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 06 Jan 2022 | 58,622 | 58,622 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 06 Jan 2022 | 18,809 | 28,809 (0%) | 0% | - | Common Stock | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 07 Jan 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | 07 Jan 2021 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock |